227 related articles for article (PubMed ID: 17191978)
1. Synthesis, and cytotoxic and antiplatelet activities of oxime- and methyloxime-containing flavone, isoflavone, and xanthone derivatives.
Wang TC; Chen IL; Lu CM; Kuo DH; Liao CH
Chem Biodivers; 2005 Feb; 2(2):253-63. PubMed ID: 17191978
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antiproliferative evaluation of amide-containing flavone and isoflavone derivatives.
Chen IL; Chen JY; Shieh PC; Chen JJ; Lee CH; Juang SH; Wang TC
Bioorg Med Chem; 2008 Aug; 16(16):7639-45. PubMed ID: 18662883
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antiproliferative, and antiplatelet activities of oxime- and methyloxime-containing flavone and isoflavone derivatives.
Wang TC; Chen IL; Lu PJ; Wong CH; Liao CH; Tsiao KC; Chang KM; Chen YL; Tzeng CC
Bioorg Med Chem; 2005 Nov; 13(21):6045-53. PubMed ID: 15990314
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives.
Lin KW; Fang SC; Hung CF; Shieh BJ; Yang SC; Teng CM; Lin CN
Arch Pharm (Weinheim); 2009 Jan; 342(1):19-26. PubMed ID: 19035386
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antiproliferative, and antiplatelet activities of oxime- and amide-containing quinolin-2(1H)-one derivatives.
Chen IL; Chang KM; Miaw CL; Liao CH; Chen JJ; Wang TC
Bioorg Med Chem; 2007 Oct; 15(20):6527-34. PubMed ID: 17689252
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and molecular docking studies of flavone and isoflavone derivatives as a novel class of KSP (kinesin spindle protein) inhibitors.
Dong JJ; Li QS; Liu ZP; Wang SF; Zhao MY; Yang YH; Wang XM; Zhu HL
Eur J Med Chem; 2013; 70():427-33. PubMed ID: 24184776
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new xanthone analogues and their biological activity test--cytotoxicity, topoisomerase II inhibition, and DNA cross-linking study.
Woo S; Jung J; Lee C; Kwon Y; Na Y
Bioorg Med Chem Lett; 2007 Mar; 17(5):1163-6. PubMed ID: 17194586
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
9. Recent cancer drug development with xanthone structures.
Na Y
J Pharm Pharmacol; 2009 Jun; 61(6):707-12. PubMed ID: 19505360
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, antileukemic and antiplatelet activities of 2,3-diaryl-6,7-dihydro-5H-1,4-diazepines.
Ramajayam R; Giridhar R; Yadav MR; Balaraman R; Djaballah H; Shum D; Radu C
Eur J Med Chem; 2008 Sep; 43(9):2004-10. PubMed ID: 18191304
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinoline and 4-anilinofuro[3,2-c]quinoline derivatives.
Chen YL; Chen IL; Wang TC; Han CH; Tzeng CC
Eur J Med Chem; 2005 Sep; 40(9):928-34. PubMed ID: 15913847
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological activities of xanthone derivatives as alpha-glucosidase inhibitors.
Liu Y; Zou L; Ma L; Chen WH; Wang B; Xu ZL
Bioorg Med Chem; 2006 Aug; 14(16):5683-90. PubMed ID: 16651002
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor activity evaluation of a novel series of xanthone derivatives.
Guo N; Liu J; Qin L; Jiang D; You X; Lu K; Teng YO; Yu P
J Asian Nat Prod Res; 2015; 17(4):377-83. PubMed ID: 25628155
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and cytotoxic evaluation of certain 4-(phenylamino)furo[2,3-b]quinoline and 2-(furan-2-yl)-4-(phenylamino)quinoline derivatives.
Zhao YL; Chen YL; Tzeng CC; Chen IL; Wang TC; Han CH
Chem Biodivers; 2005 Feb; 2(2):205-14. PubMed ID: 17191973
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological evaluation of new methyloxiranylmethoxyxanthone analogues.
Woo S; Kang DH; Nam JM; Lee CS; Ha EM; Lee ES; Kwon Y; Na Y
Eur J Med Chem; 2010 Sep; 45(9):4221-8. PubMed ID: 20619511
[TBL] [Abstract][Full Text] [Related]
16. Bromoalkoxyxanthones as promising antitumor agents: synthesis, crystal structure and effect on human tumor cell lines.
Sousa E; Paiva A; Nazareth N; Gales L; Damas AM; Nascimento MS; Pinto M
Eur J Med Chem; 2009 Sep; 44(9):3830-5. PubMed ID: 19428155
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel 1-hydroxyl-3-aminoalkoxy xanthone derivatives as potent anticancer agents.
Yang ZM; Huang J; Qin JK; Dai ZK; Lan WL; Su GF; Tang H; Yang F
Eur J Med Chem; 2014 Oct; 85():487-97. PubMed ID: 25113877
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents.
Dai M; Yuan X; Kang J; Zhu ZJ; Yue RC; Yuan H; Chen BY; Zhang WD; Liu RH; Sun QY
Eur J Med Chem; 2013 Nov; 69():159-66. PubMed ID: 24013415
[TBL] [Abstract][Full Text] [Related]
19. The synthesis and evaluation of flavone and isoflavone chimeras of novobiocin and derrubone.
Mays JR; Hill SA; Moyers JT; Blagg BS
Bioorg Med Chem; 2010 Jan; 18(1):249-66. PubMed ID: 19932969
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and molecular docking studies of novel 2-chloro-pyridine derivatives containing flavone moieties as potential antitumor agents.
Liu XH; Liu HF; Shen X; Song BA; Bhadury PS; Zhu HL; Liu JX; Qi XB
Bioorg Med Chem Lett; 2010 Jul; 20(14):4163-7. PubMed ID: 20538457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
